Corrigendum to "Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin" [Bioorg. Med. Chem. Lett. 32 (2021) 127683]
Bioorg Med Chem Lett. 2021 Apr 1:37:127836.
doi: 10.1016/j.bmcl.2021.127836.
Epub 2021 Feb 13.